Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54‐Week, Open‐Label Study

J Clin Hypertens (Greenwich). 2012; 14:821–827. ©2012 Wiley Periodicals, Inc. Combination antihypertensive therapies are recommended to attain blood pressure (BP) targets especially in high‐risk patients in whom rapid and pronounced BP control is essential. This 28‐ to 54‐week, open‐label, multicent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Hypertens (Greenwich)
Autors principals: Murray, Alexander V., Koenig, Wolfgang, Garcia‐Puig, Juan, Patel, Samir, PhD, Alkaz Uddin, Zhang, Jack
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2012
Matèries:
Original Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108980/
https://ncbi.nlm.nih.gov/pubmed/23205748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2012.00706.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars